JP2023524018A5 - - Google Patents

Info

Publication number
JP2023524018A5
JP2023524018A5 JP2022565972A JP2022565972A JP2023524018A5 JP 2023524018 A5 JP2023524018 A5 JP 2023524018A5 JP 2022565972 A JP2022565972 A JP 2022565972A JP 2022565972 A JP2022565972 A JP 2022565972A JP 2023524018 A5 JP2023524018 A5 JP 2023524018A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
pharmaceutically acceptable
acceptable salt
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022565972A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524018A (ja
JP7664947B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029641 external-priority patent/WO2021222404A1/en
Publication of JP2023524018A publication Critical patent/JP2023524018A/ja
Publication of JP2023524018A5 publication Critical patent/JP2023524018A5/ja
Application granted granted Critical
Publication of JP7664947B2 publication Critical patent/JP7664947B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022565972A 2020-04-30 2021-04-28 Il-17の調節因子としてのイミダゾリダジン Active JP7664947B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017682P 2020-04-30 2020-04-30
US63/017,682 2020-04-30
PCT/US2021/029641 WO2021222404A1 (en) 2020-04-30 2021-04-28 Imidazopyridazines as modulators of il-17

Publications (3)

Publication Number Publication Date
JP2023524018A JP2023524018A (ja) 2023-06-08
JP2023524018A5 true JP2023524018A5 (cg-RX-API-DMAC10.html) 2024-05-09
JP7664947B2 JP7664947B2 (ja) 2025-04-18

Family

ID=76197556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565972A Active JP7664947B2 (ja) 2020-04-30 2021-04-28 Il-17の調節因子としてのイミダゾリダジン

Country Status (20)

Country Link
US (3) US11691979B2 (cg-RX-API-DMAC10.html)
EP (1) EP4143195B1 (cg-RX-API-DMAC10.html)
JP (1) JP7664947B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230019507A (cg-RX-API-DMAC10.html)
CN (1) CN115884810B (cg-RX-API-DMAC10.html)
AR (1) AR121959A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021264528A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022021962A2 (cg-RX-API-DMAC10.html)
CA (1) CA3181676A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022017072A2 (cg-RX-API-DMAC10.html)
EC (1) ECSP22091485A (cg-RX-API-DMAC10.html)
ES (1) ES3036330T3 (cg-RX-API-DMAC10.html)
IL (1) IL297705A (cg-RX-API-DMAC10.html)
JO (1) JOP20220284A1 (cg-RX-API-DMAC10.html)
MX (1) MX2022013647A (cg-RX-API-DMAC10.html)
PE (1) PE20230469A1 (cg-RX-API-DMAC10.html)
TW (1) TWI874645B (cg-RX-API-DMAC10.html)
UY (1) UY39188A (cg-RX-API-DMAC10.html)
WO (1) WO2021222404A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202212967B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
US12559496B2 (en) 2020-04-30 2026-02-24 Janssen Pharmaceutica Nv Imidazopyrimidines as modulators of IL-17
JP7664947B2 (ja) * 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン
US20240140951A1 (en) * 2020-12-14 2024-05-02 UCB Biopharma SRL Imidazopyridazine derivatives as il-17 modulators
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
AU2022348938A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
AU2022349687A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
WO2023111181A1 (en) 2021-12-16 2023-06-22 Leo Pharma A/S Small molecule modulators of il-17
CN118580191A (zh) * 2022-01-28 2024-09-03 和记黄埔医药(上海)有限公司 用于制备咪唑并[1,2-b]哒嗪类化合物的中间体
EP4486737A1 (en) 2022-03-04 2025-01-08 LEO Pharma A/S Small molecule modulators of il-17
KR20250023378A (ko) * 2022-05-19 2025-02-18 다이스 알파, 인크. 락탐 치환된 이미다조피리다진 il-17a 조정제 및 그의 용도
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
CN115806503B (zh) * 2022-12-02 2025-03-07 中国海洋大学 一种选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
EP4688156A1 (en) * 2023-03-28 2026-02-11 Janssen Pharmaceutica NV Lactam-containing imidazopyridazine il-17 inhibitor compounds
WO2024215597A1 (en) * 2023-04-11 2024-10-17 Dice Alpha, Inc. Substituted 6-imidazopyridazine il-17a modulators and uses thereof
WO2025202931A1 (en) 2024-03-27 2025-10-02 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
WO2025247285A1 (zh) * 2024-05-28 2025-12-04 西藏海思科制药有限公司 一种可抑制il-17a的杂环化合物制备及其用途
WO2026080825A1 (en) * 2024-10-10 2026-04-16 Revolution Medicines, Inc. Synthesis of ras inhibitors
WO2026130488A1 (en) * 2024-12-18 2026-06-25 Anew Therapeutics Pte. Ltd. Heterocyclic compounds as il-17 inhibitors

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10208349B2 (en) 2011-01-07 2019-02-19 Ucb Biopharma Sprl Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
EP2892899B1 (en) * 2012-09-06 2018-03-21 Bristol-Myers Squibb Company Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WO2014066726A2 (en) 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
WO2014181287A1 (en) 2013-05-09 2014-11-13 Piramal Enterprises Limited Heterocyclyl compounds and uses thereof
US10035777B2 (en) 2014-08-05 2018-07-31 Bristol-Myers Squibb Company Heterocyclic kinase inhibitors
KR102782807B1 (ko) * 2015-11-18 2025-03-14 브리스톨-마이어스 스큅 컴퍼니 Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
CN111601799B (zh) * 2018-01-15 2023-06-09 Ucb生物制药有限责任公司 作为Il-17调节剂的稠合咪唑衍生物
WO2019223718A1 (zh) 2018-05-22 2019-11-28 成都先导药物开发股份有限公司 一种免疫调节剂
EP3599245A1 (en) 2018-07-27 2020-01-29 Dompé farmaceutici S.p.A. Il-17a binding polypeptides and medical uses thereof
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
GB201820165D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
GB201820316D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for IL-17
MX2021006421A (es) 2018-12-19 2021-08-16 Leo Pharma As Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
CN113874080B (zh) 2019-02-06 2024-09-27 戴斯阿尔法公司 Il-17a调节剂及其用途
EP3935051A1 (en) 2019-03-08 2022-01-12 Leo Pharma A/S Small molecule modulators of il-17
GB201909191D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909194D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
WO2021027721A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341442B (zh) 2019-08-09 2021-10-22 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341439B (zh) 2019-08-09 2022-02-15 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341451B (zh) 2019-08-09 2022-06-17 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021027722A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341435B (zh) 2019-08-09 2021-10-22 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021027729A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341429B (zh) 2019-08-09 2021-11-23 成都先导药物开发股份有限公司 一种免疫调节剂的中间体化合物
CN112341450B (zh) 2019-08-09 2022-05-17 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021170631A1 (en) 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
WO2021170627A1 (en) 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
CN115702024A (zh) 2020-04-07 2023-02-14 Ucb生物制药有限责任公司 用作il-17调节剂的二氟环己基衍生物
WO2021204800A1 (en) 2020-04-07 2021-10-14 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
JP7664947B2 (ja) * 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン
KR20230017211A (ko) * 2020-04-30 2023-02-03 얀센 파마슈티카 엔.브이. Il-17 경로의 조절인자를 식별하는 방법

Similar Documents

Publication Publication Date Title
JP2024536869A5 (cg-RX-API-DMAC10.html)
JP2024050527A5 (cg-RX-API-DMAC10.html)
JP2024536863A5 (cg-RX-API-DMAC10.html)
AU2019202144B2 (en) Solid forms of {(5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino}acetic acid, compositions, and uses thereof
JP2023520925A5 (cg-RX-API-DMAC10.html)
ES2316575T3 (es) Derivado de fenilpiridincarbonilpiperazina.
JP2006506425A5 (cg-RX-API-DMAC10.html)
DE69521645T2 (de) Pyridinderivate
JP2023523770A5 (cg-RX-API-DMAC10.html)
ES2401052T3 (es) Derivados éster como inhibidores de fosfodiesterasa
JP2023515617A5 (cg-RX-API-DMAC10.html)
RU2003105805A (ru) Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1
JP2004504301A5 (cg-RX-API-DMAC10.html)
JP2018519323A5 (cg-RX-API-DMAC10.html)
JP2015512435A5 (cg-RX-API-DMAC10.html)
JP2019034943A5 (cg-RX-API-DMAC10.html)
JPWO2023106310A5 (cg-RX-API-DMAC10.html)
JP2023504415A5 (cg-RX-API-DMAC10.html)
JP2008505171A5 (cg-RX-API-DMAC10.html)
CA2628844A1 (en) Pyrazole derivatives and their medical use
JP2022548247A5 (cg-RX-API-DMAC10.html)
JP2004502670A5 (cg-RX-API-DMAC10.html)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
CA2575777A1 (en) Compositions and methods for treatment of colitis using methimazole and/or cyclic thione derivatives
JP2022504620A5 (cg-RX-API-DMAC10.html)